As reported, mutations in specific genes lead to an increase in the development of some types of tumours, as the risk of breast cancer for BRCA1/2 mutation carriers is 60–80%, while that of ovarian cancer is 20–45%. This evidence concerns the gene BRCA1 and ovarian cancer.